Limits...
The Alpha-defensin Test for Periprosthetic Joint Infection Responds to a Wide Spectrum of Organisms.

Deirmengian C, Kardos K, Kilmartin P, Gulati S, Citrano P, Booth RE - Clin. Orthop. Relat. Res. (2015)

Bottom Line: Median alpha-defensin levels were calculated for each group, and Dunn's multiple comparison test for nonparametric data was used to identify any statistically significant (p < 0.05) organism-specific differences in the alpha-defensin level.The alpha-defensin test provides consistent results regardless of the organism type, Gram type, species, or virulence of the organism and should be seriously considered to be a standard diagnostic tool in the evaluation for PJI.Level III, diagnostic study.

View Article: PubMed Central - PubMed

Affiliation: CD Diagnostics Inc, Claymont, DE, USA.

ABSTRACT

Background: The alpha-defensin test has been previously demonstrated to be highly accurate in the diagnosis of prosthetic joint infection (PJI), nearly matching the Musculoskeletal Infection Society definition for PJI. However, the relationship between alpha-defensin levels and differing infecting organism has not yet been investigated.

Questions/purposes: The purpose of this study is to describe the breadth of organisms that can trigger a positive synovial fluid alpha-defensin test result in the setting of PJI and also to assess the magnitude of the alpha-defensin result in terms of various pathogen characteristics.

Methods: Between December 2012 and March 2014, one laboratory processed 2319 synovial fluid samples for alpha-defensin testing. The present study reviewed the results of the 1937 samples that simultaneously had a synovial fluid culture performed; these came from 418 surgeons in 42 states. The overall culture-positive rate was 49% (244 of 498) among alpha-defensin-positive synovial fluids and 1% (19 of 1439) among alpha-defensin-negative synovial fluids. The organisms recovered from 244 alpha-defensin-positive, culture-positive fluids were recorded and grouped based on various characteristics, including Gram type, species, virulence, oral pathogenicity, and source joint. Alpha-defensin-negative samples served as uninfected controls. Median alpha-defensin levels were calculated for each group, and Dunn's multiple comparison test for nonparametric data was used to identify any statistically significant (p < 0.05) organism-specific differences in the alpha-defensin level.

Results: The alpha-defensin test for PJI was positive in the setting of a wide spectrum of organisms typically causing PJI. The median alpha-defensin level for all 244 alpha-defensin-positive, culture-positive samples (4.7 [interquartile range {IQR}, 3.7-5.3]) was higher than negative controls (0.26 [IQR, 0.22-0.33]) with a median difference of 4.4 (p < 0.001). There were no differences in the median alpha-defensin levels when performing a multiple comparison test among Gram-positive organisms (4.7 [IQR, 3.6-5.3]), Gram-negative organisms (4.8 [IQR, 4.2-5.3]), yeast (4.1 [IQR, 2.2-5.1]), virulent organisms (4.7 [IQR, 3.8-5.2]), less virulent organisms (4.8 [IQR, 3.6-5.4]), oral pathogens (4.5 [IQR, 3.2-5.2]), knees (4.7 [IQR, 3.7-5.3]), hips (4.9 [IQR, 4.1-5.8]), or shoulders (5.3 [IQR, 4.0-10.7]) with all comparisons having a p > 0.999.

Conclusions: The alpha-defensin test provides consistent results regardless of the organism type, Gram type, species, or virulence of the organism and should be seriously considered to be a standard diagnostic tool in the evaluation for PJI. Future research should focus on the performance of this test in specific clinical scenarios such as the immediate postoperative period in the setting of severe immunocompromise and in the setting of a native joint.

Level of evidence: Level III, diagnostic study.

Show MeSH

Related in: MedlinePlus

Synovial fluid samples, from patients undergoing arthroplasty, having both an alpha-defensin test and synovial fluid culture, were included in this study. The figure depicts the overall breakdown of results.
© Copyright Policy - OpenAccess
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4457768&req=5

Fig1: Synovial fluid samples, from patients undergoing arthroplasty, having both an alpha-defensin test and synovial fluid culture, were included in this study. The figure depicts the overall breakdown of results.

Mentions: Of the 498 alpha-defensin-positive synovial fluid samples, 244 (49%) were also culture-positive. Of 1439 alpha-defensin-negative samples, only 19 (1%) were culture-positive (Fig. 1). A wide spectrum of organisms was isolated from the 244 synovial fluid samples that were positive for both alpha-defensin and culture (Table 1). Gram-positive bacteria alone, Gram-negative bacteria alone, and yeast alone were isolated from 210 (86%), 23 (9%), and six (3%) of these 244 samples, respectively. Five cultures (2%) had polymicrobial growth. Among the 244 culture-positive synovial fluid samples, 77 (30%) resulted in growth of an organism classified as virulent, 167 (70%) resulted in growth of an organism classified as less virulent, and 24 (10%) resulted in growth of an organism classified as an oral pathogen.Fig. 1


The Alpha-defensin Test for Periprosthetic Joint Infection Responds to a Wide Spectrum of Organisms.

Deirmengian C, Kardos K, Kilmartin P, Gulati S, Citrano P, Booth RE - Clin. Orthop. Relat. Res. (2015)

Synovial fluid samples, from patients undergoing arthroplasty, having both an alpha-defensin test and synovial fluid culture, were included in this study. The figure depicts the overall breakdown of results.
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4457768&req=5

Fig1: Synovial fluid samples, from patients undergoing arthroplasty, having both an alpha-defensin test and synovial fluid culture, were included in this study. The figure depicts the overall breakdown of results.
Mentions: Of the 498 alpha-defensin-positive synovial fluid samples, 244 (49%) were also culture-positive. Of 1439 alpha-defensin-negative samples, only 19 (1%) were culture-positive (Fig. 1). A wide spectrum of organisms was isolated from the 244 synovial fluid samples that were positive for both alpha-defensin and culture (Table 1). Gram-positive bacteria alone, Gram-negative bacteria alone, and yeast alone were isolated from 210 (86%), 23 (9%), and six (3%) of these 244 samples, respectively. Five cultures (2%) had polymicrobial growth. Among the 244 culture-positive synovial fluid samples, 77 (30%) resulted in growth of an organism classified as virulent, 167 (70%) resulted in growth of an organism classified as less virulent, and 24 (10%) resulted in growth of an organism classified as an oral pathogen.Fig. 1

Bottom Line: Median alpha-defensin levels were calculated for each group, and Dunn's multiple comparison test for nonparametric data was used to identify any statistically significant (p < 0.05) organism-specific differences in the alpha-defensin level.The alpha-defensin test provides consistent results regardless of the organism type, Gram type, species, or virulence of the organism and should be seriously considered to be a standard diagnostic tool in the evaluation for PJI.Level III, diagnostic study.

View Article: PubMed Central - PubMed

Affiliation: CD Diagnostics Inc, Claymont, DE, USA.

ABSTRACT

Background: The alpha-defensin test has been previously demonstrated to be highly accurate in the diagnosis of prosthetic joint infection (PJI), nearly matching the Musculoskeletal Infection Society definition for PJI. However, the relationship between alpha-defensin levels and differing infecting organism has not yet been investigated.

Questions/purposes: The purpose of this study is to describe the breadth of organisms that can trigger a positive synovial fluid alpha-defensin test result in the setting of PJI and also to assess the magnitude of the alpha-defensin result in terms of various pathogen characteristics.

Methods: Between December 2012 and March 2014, one laboratory processed 2319 synovial fluid samples for alpha-defensin testing. The present study reviewed the results of the 1937 samples that simultaneously had a synovial fluid culture performed; these came from 418 surgeons in 42 states. The overall culture-positive rate was 49% (244 of 498) among alpha-defensin-positive synovial fluids and 1% (19 of 1439) among alpha-defensin-negative synovial fluids. The organisms recovered from 244 alpha-defensin-positive, culture-positive fluids were recorded and grouped based on various characteristics, including Gram type, species, virulence, oral pathogenicity, and source joint. Alpha-defensin-negative samples served as uninfected controls. Median alpha-defensin levels were calculated for each group, and Dunn's multiple comparison test for nonparametric data was used to identify any statistically significant (p < 0.05) organism-specific differences in the alpha-defensin level.

Results: The alpha-defensin test for PJI was positive in the setting of a wide spectrum of organisms typically causing PJI. The median alpha-defensin level for all 244 alpha-defensin-positive, culture-positive samples (4.7 [interquartile range {IQR}, 3.7-5.3]) was higher than negative controls (0.26 [IQR, 0.22-0.33]) with a median difference of 4.4 (p < 0.001). There were no differences in the median alpha-defensin levels when performing a multiple comparison test among Gram-positive organisms (4.7 [IQR, 3.6-5.3]), Gram-negative organisms (4.8 [IQR, 4.2-5.3]), yeast (4.1 [IQR, 2.2-5.1]), virulent organisms (4.7 [IQR, 3.8-5.2]), less virulent organisms (4.8 [IQR, 3.6-5.4]), oral pathogens (4.5 [IQR, 3.2-5.2]), knees (4.7 [IQR, 3.7-5.3]), hips (4.9 [IQR, 4.1-5.8]), or shoulders (5.3 [IQR, 4.0-10.7]) with all comparisons having a p > 0.999.

Conclusions: The alpha-defensin test provides consistent results regardless of the organism type, Gram type, species, or virulence of the organism and should be seriously considered to be a standard diagnostic tool in the evaluation for PJI. Future research should focus on the performance of this test in specific clinical scenarios such as the immediate postoperative period in the setting of severe immunocompromise and in the setting of a native joint.

Level of evidence: Level III, diagnostic study.

Show MeSH
Related in: MedlinePlus